CGEM- Cullinan Therapeutics, Inc.

Name: Cullinan Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Cullinan Therapeutics, Inc. (CGEM) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CGEM is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Lynx1 Capital Management LP	8.96M	$146.37M	-
CEO	Ahmed Nadim	420.7K	$6.87M	-
Other	Jones Jeffrey Alan	169.5K	$2.77M	-
Other	Sumer Jacquelyn L	135.4K	$2.21M	-
Other	Michaelson Jennifer	132.6K	$2.17M	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 18, 2023	Trigilio Jeffrey51	Chief Financial Officer	Sell	399	$8.76	$3,495.24	-0.5%	+13.9%	+163.3%
May 12, 2023	Michaelson Jennifer65	Chief Development Officer	Sell	193	$8.78	$1,694.54	-0.2%	+5.4%	+172.2%
May 12, 2023	Trigilio Jeffrey51	Chief Financial Officer	Sell	347	$8.78	$3,046.66	-0.4%	+5.4%	+172.2%
Apr 25, 2023	Ahmed Nadim49	President And CEO	Sell	716	$10.59	$7,582.44	-0.6%	-1.1%	+81.1%
Apr 18, 2023	Jones Jeffrey Alan	Chief Medical Officer	Sell	392	$10.71	$4,198.32	-0.7%	+10.3%	+74.1%
Apr 18, 2023	Trigilio Jeffrey51	Chief Financial Officer	Sell	398	$10.71	$4,262.58	-0.5%	+10.3%	+74.1%
Apr 18, 2023	Michaelson Jennifer65	Chief Development Officer	Sell	238	$10.71	$2,548.98	-0.3%	+10.3%	+74.1%
Apr 18, 2023	Sumer Jacquelyn L	Chief Legal Officer	Sell	290	$10.71	$3,105.90	-0.6%	+10.3%	+74.1%
Apr 12, 2023	Trigilio Jeffrey51	Chief Financial Officer	Sell	318	$10.22	$3,249.96	-0.4%	+1.1%	+74.9%
Apr 12, 2023	Michaelson Jennifer65	Chief Development Officer	Sell	176	$10.22	$1,798.72	-0.2%	+1.1%	+74.9%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC